8th Heart in Diabetes (HiD)  

Dates: June 7-9, 2024 

Abstract Submission Deadline: April 19, 2024

  • Accepted Abstracts will be published in American Heart Journal, Editor-in-Chief: Daniel Mark, MD, MPH
  • Accepted Abstracts will have a poster presentation at the meeting.
  • Top Abstracts will be selected for oral presentation at the meeting.
  • The top 4 Abstracts will receive awards and cash prizes.

Accepted Abstracts will receive 50% OFF All-Access/General Admission Tickets 

To be published in the American Heart Journal and to present a poster at the conference, the author(s) must register for the 8th annual Heart in Diabetes Conference. **

ePosters are due April 30, 2024.

If an author wishes to make changes or withdraw their abstract, they must contact our staff no later than 

April 26, 2024. ePosters are pdf copies that will be displayed on our virtual platform.

Abstract Submission Topics

Abstracts should address state-of-the-art clinical research aspects of diabetes and the heart. (As an example, obesity by itself will NOT qualify, but obesity as it relates to diabetes and/or cardiovascular disease will qualify). 

Topics Include: diabetes, hypoglycemia, prediabetes, and/or cardiometabolic syndrome, retinopathy, obesity, neuropathy, dyslipidemia, triglycerides, cholesterol, hypertension, congestive heart failure (CHF), atherosclerosis, cardiovascular disease, arrhythmia, kidney/renal disease, cardiorenal syndrome, thrombosis, coagulation abnormalities, therapeutics, clinical trials, cardiovascular outcome trials, epidemiology, fatty liver, inflammation, guidelines on practice, technology, peripheral vascular disease, and related conditions. Although the posters are not designed for basic science, abstracts that consider unknown MOA (mode of action) of medications or pathophysiology of related medical conditions may be accepted.   

Abstract Poster Presentations

Abstracts may be submitted for poster presentation. If selected for poster presentation, the author(s) or presenter(s) are required to register for the Congress and to be present during the poster sessions. The presenter in attendance must be one of the authors listed on the abstract. Poster Presentation Session Time and Date TBA. 


Abstract Oral Presentations

Four of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session - Time and Date TBA  (once ready, 7th HiD agenda may be viewed at heartindiabetes.com/agenda). In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by a 5 minute period of Q&A. If selected, an author is required to register to the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document in order to be considered for and to present their work at the abstract oral session.   ​ 

Top Abstract Awards

Awards will be given to the highest ranking abstracts. The award levels are: Gold, Silver, Bronze and honorable mention.    

**Please note: If an author wishes to make changes or withdraw their abstract, they must contact our staff no later than May 10, 2024. HiD cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. Any requests should be submitted via e-mail to info@tmioa.com.

In addition:

  • Abstracts and scientific materials presented at the 8th Annual Heart in Diabetes (2024) must not have been published or presented prior to June 07, 2024, other than in abstract form.
  • Encore abstracts are accepted under special circumstances, provided that upon selection at least one of the authors should be registered for the conference and is present on-site to present their posters during the meeting. Please note that Encore abstracts will not be published under the American Heart Journal and will not be eligible for oral abstract presentations or awards.
  • All abstracts must be submitted electronically in Microsoft Word format and should be no more than 250 words (Titles, author(s) names, and affiliations are not included in the word count).
  • Graphs or figures submitted must be in TIFF or JPG format.
  • All materials must arrive on or before the abstract deadline noted above.
  • Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.
  • Authorship on multiple abstracts is permitted.
  • All submitted content will be graded by the 2024 Heart in Diabetes Scientific Abstract Committee.
  • Abstracts will be published in an issue of the American Heart Journal. Click on the images to see a sample of the recently published works.  


The Abstract Poster Reception at the Exhibit Hall starts on Friday, June 7, from 6:15 pm to 7:15 pm. Early Poster Set-up will be available on Thursday, June 6, 2024, from 11:00 am to 6:00 pm. Please have your posters placed on your designated board before the day of the conference, as the Exhibit Hall opens on Friday, June 7, 2024, at 7:00 am.

Late Breaking Abstract Submission Deadline: April 30, 2024

  • Accepted Abstracts will be published in American Heart Journal, Editor-in-Chief: Daniel Mark, MD, MPH
  • Accepted Abstracts will have poster presentation at the meeting.
  • Top Abstracts will be selected for oral presentation at the meeting.
  • Top 4 Abstracts will receive awards and cash prizes.

Upon being accepted, deadline for abstract e-posters submissions is April 26, 2024

The Abstract Oral Presentation is on Saturday, June 8 , 2024, starting at 8:00 pm to 9:00 pm.

The Oral Abstract Winner Award Presentation is on Sunday, June 9, 2024, at 8:00 am.

Important Notice:  "Make sure you include in all abstracts involving human or animal  studies state approval by ethics committees as well as authors’ affiliation in detail and country of origin."



We are delighted that you have accepted our invitation to participate in the 21st annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Continuing Medical Education (CME) Conference. This conference is a live in-person event with a component of on-demand and will be held from December 7-9, 2023 at the Hilton Universal (555 Universal Hollywood Dr, Universal City, CA 91608). For more information, please visit our website at wcir.org

Honorarium as permissible, travel expenses, and suitable accommodations will be covered in accordance with government, sunshine act, and ACCME rules and guidelines. If you have any questions or need additional information please contact our office at (818) 342-1889 or email info@tmioa.com

We greatly appreciate your participation in this very exciting and important endeavor. Please proceed to provide all CME-required information. We look forward to having you be a part of the 21st WCIRDC in Los Angeles!

Best Regards,